Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-133,333
Closed -$480K 21
2025
Q4
$480K Hold
133,333
﹤0.01% 17
2025
Q3
$619K Buy
133,333
+132,666
+19,890% +$849K 0.01% 17
2025
Q2
$7.64K Hold
667
﹤0.01% 20
2025
Q1
$116K Hold
667
﹤0.01% 23
2024
Q4
$159K Hold
667
﹤0.01% 27
2024
Q3
$304K Hold
667
0.03% 24
2024
Q2
$340K Hold
667
0.03% 26
2024
Q1
$845K Hold
667
0.05% 26
2023
Q4
$967K Hold
667
0.05% 21
2023
Q3
$1.97M Hold
667
0.09% 22
2023
Q2
$2.6M Hold
667
0.09% 21
2023
Q1
$3.2M Buy
+667
New +$4.58M 0.1% 21

Other funds holding NCNA

Carlyle Group's NCNA Position: Q1 2026 in Review

Carlyle Group sold out of NuCana (NCNA) in Q1 2026, closing a stake of 133,333 shares — an estimated $480K sold.

Carlyle Group first reported a position in NCNA in Q1 2023 and held it in 12 quarters. The position peaked at $3.2M in Q1 2023. 8 funds tracked by Wall St. Rank hold NCNA as of Q1 2026.

  • Carlyle Group reported no remaining NuCana position as of Q1 2026 after selling out during the quarter.
  • Carlyle Group sold 133,333 NuCana shares in Q1 2026, an estimated $480K.
  • Carlyle Group first reported a position in NuCana in Q1 2023 and held it in 12 quarters.
  • Carlyle Group's NuCana position peaked at $3.2M in Q1 2023.
  • 8 funds tracked by Wall St. Rank held NuCana as of Q1 2026.

Based on Carlyle Group's 13F filing for Q1 2026, filed 8 May 2026.